Health News Archive - January 14, 2009
The elderly may have higher blood pressure in cold weather, researchers in France said. Dr.
SEATTLE, Jan. 14 /PRNewswire-FirstCall/ -- In meetings held in association with the JP Morgan Healthcare Conference in San Francisco, Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) reviewed 2009 targeted milestones and 2008 accomplishments.
BILTHOVEN, The Netherlands, January 14 /PRNewswire/ -- Progentix Orthobiology B.V. announced today that it has closed an investment agreement with NuVasive, a medical device company focused on developing products for minimally disruptive surgical treatments for the spine.
MIAMI, Jan. 14 /PRNewswire/ -- The National Ovarian Cancer Coalition (NOCC) announced that body image | body essence, an art exhibition of 16 sculptures depicting various stages of ovarian cancer, will be on display at the University of Miami, College of Arts and Sciences Gallery, from Jan.
OSLO, Norway, January 14 /PRNewswire-FirstCall/ -- - Results Highlight the Potential of Alpharadin to Treat Bone Metastases in Major Cancer Indications Algeta ASA (OSE: ALGETA), the cancer therapeutics company, announces that with the results of the BC1-04 study reported today it has completed its comprehensive phase II clinical program evaluating Alpharadin (radium-223) as a new treatment for bone metastases in patients with hormone-refractory prostate cancer (HRPC).
CHICAGO, Jan. 14 /PRNewswire-USNewswire/ -- Celebrating 'Cones for Kids' 28th year, Friendly Ice Cream Corporation has launched its annual Valentine's Day fundraiser to benefit local Easter Seals Camp programs.
POWAY, Calif., Jan.
LONDON, Jan. 14 /PRNewswire/ -- The pharmaceutical industry is currently facing some key challenges. The increase in drug development costs, a decrease in the number of drugs being approved, and scrutiny from regulatory authorities are forcing companies to look at alternative revenue generators.
LONDON, Jan. 14 /PRNewswire/ -- The vaccines market, which was earlier associated with low profit margins and slow growth rates, has gained momentum in recent years through innovation.
ST. LOUIS, Jan. 14 /PRNewswire-FirstCall/ -- At the Boston Atrial Fibrillation Symposium, Stereotaxis, Inc.